Evaluating the Effectiveness of ChemoNurs: A Mobile Chemotherapy Drug Guide for Oncology Nurses

NCT06976450 | Completed

• 1 other identifier: 2022.216.IRB3.099
• Study Type: interventional
• Target: 59
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to evaluate the effectiveness of a mobile chemotherapy drug guide application, ChemoNurs, developed for oncology nurses, in improving their knowledge and attitudes toward chemotherapy practices. H1: The mobile chemotherapy drug guide developed for oncology nurses increases their knowledge related to chemotherapy. H2: The mobile chemotherapy drug guide developed for oncology nurses promotes the development of positive attitudes toward chemotherapy. H3: The mobile chemotherapy drug guide developed for oncology nurses increases their satisfaction.

Conditions

Chemotherapy

Outcome Measures

Primary Outcomes (2)

• Change in Chemotherapy Knowledge Score

  This outcome evaluates the improvement in oncology nurses' knowledge of chemotherapy administration, assessed through the Chemotherapy Practice Knowledge Scale for Oncology Nurses. The items are scored to assess nurses' knowledge related to chemotherapy practices using a 3-point Likert scale: "I have knowledge = 3," "I am unsure = 2," and "I have no knowledge = 1." The scale consists of 44 items and four subdimensions. The total score ranges from a minimum of 44 to a maximum of 132, with higher scores indicating greater knowledge regarding chemotherapy administration.

  Baseline (Month 0), Midpoint (Month 3), and Endpoint (Month 6)

• Change in Attitudes Toward Chemotherapy Practices

  This outcome measures changes in the attitudes of oncology nurses toward chemotherapy practices, using the Attitude Scale for Oncology Nurses Regarding Chemotherapy Practices. This scale was developed by Khan et al. (2012) to evaluate the attitudes of cancer nurses toward chemotherapy practices. It is a 4-point Likert-type scale with the following response options: 4 = Strongly Agree, 3 = Agree, 2 = Disagree, 1 = Strongly Disagree. The scale consists of two subdimensions: negative attitude (6 items) and positive attitude (4 items). The items under the negative attitude subdimension are reverse-scored when calculating the total score. The overall score ranges from a minimum of 10 to a maximum of 40, with higher scores indicating more positive attitudes toward chemotherapy practices.

  Baseline (Month 0), Midpoint (Month 3), and Endpoint (Month 6)

Secondary Outcomes (2)

• Mobile Application Usability

  Month 3 and Month 6

• Nurses' Satisfaction with CHEMONURS Application

  Month 6

Study Arms (2)

Application Group

EXPERIMENTAL

Participants in the experimental group were oncology nurses employed at Hacettepe University Oncology Hospital who were provided access to CHEMONURS, a mobile chemotherapy drug guide application developed to support clinical decision-making and professional development. After completing a demographic form and baseline assessments using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, participants received a demo version of the app via a WhatsApp link. They were instructed to download the application onto their personal smartphones and use it freely over a six-month period during their routine clinical practice. No restrictions were placed on usage frequency to reflect real-world applicability; usage was monitored through embedded app analytics and nurse feedback. Daily reminders and follow-up communications were used to encourage continued engagement. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months.

Other: ChemoNurs Mobile Application Group; Device: Personal Smartphone

Standard Practice

NO INTERVENTION

Participants in the control group were oncology nurses working at Hacettepe University Oncology Hospital who continued with their routine clinical duties without access to the CHEMONURS mobile application or any additional educational intervention. After completing the baseline assessment using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, no further intervention was provided. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months, in parallel with the experimental group, to evaluate changes over time in the absence of the mobile application.

Interventions

ChemoNurs Mobile Application Group OTHER

Participants in the mobile app group were oncology nurses employed at Hacettepe University Oncology Hospital who were provided access to CHEMONURS, a mobile chemotherapy drug guide application developed to support clinical decision-making and professional development. After completing a demographic form and baseline assessments using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, participants received a demo version of the app via a WhatsApp link. They were instructed to download the application onto their personal smartphones and use it freely over a six-month period during their routine clinical practice. No restrictions were placed on usage frequency to reflect real-world applicability; usage was monitored through embedded app analytics and nurse feedback. Daily reminders and follow-up communications were used to encourage continued engagement. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months. U

Application Group

Personal Smartphone DEVICE

Used by participants to access and interact with the CHEMONURS mobile application during the study period.

Application Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Actively administering chemotherapy treatments
• Having knowledge of how to use an Android or iOS smartphone
• Possessing mobile literacy
• Working in oncology clinics for a duration of 0-12 months
• Volunteering to participate in the study

You may not qualify if:

• Not having completed the orientation process in oncology clinics
• Not having administered chemotherapy
• Incomplete responses in the data collection forms
• Willingness to withdraw at any stage of the study
• Participation in the Oncology Nursing Certification Program
• Prior attendance in courses or training sessions related to chemotherapy drugs

Sponsors & Collaborators

• Koç University: lead
• The Scientific and Technological Research Council of Turkey: collaborator

Study Sites (1)

Hacettepe University Oncology Hospital

Ankara, Altındağ, 06230, Turkey (Türkiye)

Location

Study Officials

• Remziye Semerci Şahin, Assistant professor

  Koç University

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: An independent statistician and a doctoral student working as a research assistant were responsible for the randomization and group assignment processes. Their involvement ensured the systematic conduct of the study and helped control selection bias through randomized allocation and allocation concealment. Due to the researcher's awareness of the intervention, blinding during the implementation phase was not feasible.
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 9, 2025
• First Posted: May 16, 2025
• Study Start: August 1, 2023
• Primary Completion: August 1, 2024
• Study Completion: May 1, 2025
• Last Updated: September 2, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)